SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001633070-21-000057
Filing Date
2021-11-10
Accepted
2021-11-10 16:18:54
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axla-20210930.htm   iXBRL 10-Q 1434183
2 EX-31.1 exhibit311q32021.htm EX-31.1 10576
3 EX-31.2 exhibit312q32021.htm EX-31.2 10447
4 EX-32.2 exhibit321q32021.htm EX-32.2 7229
10 GRAPHIC axla-20210930_g1.jpg GRAPHIC 87693
  Complete submission text file 0001633070-21-000057.txt   5411390

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axla-20210930.xsd EX-101.SCH 28000
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axla-20210930_cal.xml EX-101.CAL 49730
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axla-20210930_def.xml EX-101.DEF 110287
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axla-20210930_lab.xml EX-101.LAB 435181
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axla-20210930_pre.xml EX-101.PRE 262408
11 EXTRACTED XBRL INSTANCE DOCUMENT axla-20210930_htm.xml XML 731314
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38901 | Film No.: 211396922
SIC: 2836 Biological Products, (No Diagnostic Substances)